Steroid HE3286 Chemoenzymatic Synthesis for Higher Yield
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing synthetic routes for steroid HE3286 are lengthy, cumbersome, and result in low overall yield, making them unsuitable for large-scale industrial production.
Innovation Solution
A chemoenzymatic method utilizing the P450 BM3 mutant LG-23 for 7β-hydroxylation of dehydroepiandrosterone, followed by chemical ethynylation to synthesize steroid HE3286, employing enzymatic catalysis and chemical alkynylation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional synthetic routes are used for steroid HE3286, then the synthesis can be completed, but the overall yield is low and the synthesis route is lengthy
Solution Approach 1:
The patent replaces conventional chemical synthesis methods with an enzymatic catalysis system. Specifically, it uses a P450 BM3 mutant enzyme to catalyze the hydroxylation reaction at the C7β position, substituting multiple chemical steps with a single enzymatic transformation. This substitution dramatically simplifies the synthesis route and improves overall yield by eliminating unnecessary intermediate steps and reducing material loss.
Solution Approach 2:
The patent modifies the enzymatic reaction parameters by using a specific P450 BM3 mutant enzyme with optimized catalytic properties. The enzyme mutant LG-23 was specifically designed to enhance catalytic efficiency and selectivity for the C7β-hydroxylation reaction. By optimizing parameters such as enzyme concentration, substrate concentration, co-factor regeneration system, and reaction temperature, the patent achieves high yield and simplified synthesis compared to conventional chemical methods.
2Productivity
If conventional synthetic routes are used for steroid HE3286, then the target compound can be obtained, but the reaction pathway is prolonged and operations are cumbersome
Solution Approach 1:
The patent replaces multi-step chemical reactions with a single enzymatic catalysis step. The P450 BM3 mutant enzyme directly catalyzes the transformation of dehydroepiandrosterone to 7β-hydroxy-dehydroepiandrosterone in one step, eliminating the need for multiple intermediate steps including protection, oxidation, reduction, and deprotection operations that are required in conventional chemical synthesis routes.
Solution Approach 2:
The patent segments the synthesis process into two distinct parts: an enzymatic catalysis step for hydroxylation and a chemical alkynylation step for introducing the ethynyl group. This segmentation allows each step to be optimized independently, with the enzymatic step providing high efficiency and selectivity, and the chemical step completing the transformation. This segmentation reduces overall reaction time compared to conventional sequential chemical steps.
3Productivity
If conventional synthetic routes are used for steroid HE3286, then the compound can be synthesized, but the synthesis cost is high
Solution Approach 1:
The patent replaces conventional chemical synthesis with enzymatic catalysis, which operates under milder conditions and with higher atom economy. The P450 BM3 mutant enzyme catalyzes the hydroxylation reaction with high selectivity, producing the desired product with minimal byproducts and waste. This substitution reduces material loss and lowers synthesis costs compared to conventional chemical methods that require multiple steps and generate significant waste.
Solution Approach 2:
The patent implements a co-factor regeneration system that recovers and reuses NADP+ cofactor in the enzymatic reaction. The cofactor is regenerated from NADPH through oxidation by a co-factor regeneration system, allowing it to be reused in subsequent catalytic cycles. This recovery mechanism significantly reduces the need for continuous addition of expensive cofactors and minimizes material waste, thereby lowering overall synthesis costs.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method simplifies the synthesis route, enhances yield, reduces byproducts, and achieves high efficiency with mild reaction conditions and low costs, suitable for industrial production.
Implementation Method 1
converting dehydroepiandrosterone into 7β-hydroxy-dehydroepiandrosterone under the action of 7β-hydroxylase
Implementation Method 2
The 7β-hydroxylase is a cytochrome P450 enzyme, specifically a P450 BM3 mutant
Implementation Method 3
alkynylating the carbonyl group at the C17th position of 7β-hydroxy-dehydroepiandrosterone to obtain steroid HE3286
Data Source
AI summary
A chemoenzymatic method for synthesizing steroid HE3286 is provided, comprising: screening cytochrome P450 mutant LG-23 capable of catalyzing 7β-hydroxylation of dehydroepiandrosterone; enzymatically converting dehydroepiandrosterone to 7β-hydroxy-dehydroepiandrosterone using the P450 BM3 mutant enzyme; and chemically performing alkynylation at the C17th position carbonyl group to generate steroid HE3286. The steroid HE3286 synthesis method not only features simplified synthetic steps and high catalytic selectivity, but also offers mild reaction conditions, low cost, and environmentally friendly efficiency. This approach holds significant application value for advancing the development of steroid pharmaceuticals.